CN116640757A - Construction method and application of immobilized enzyme system based on artificial antibody-antigen - Google Patents
Construction method and application of immobilized enzyme system based on artificial antibody-antigen Download PDFInfo
- Publication number
- CN116640757A CN116640757A CN202310617202.XA CN202310617202A CN116640757A CN 116640757 A CN116640757 A CN 116640757A CN 202310617202 A CN202310617202 A CN 202310617202A CN 116640757 A CN116640757 A CN 116640757A
- Authority
- CN
- China
- Prior art keywords
- enzyme
- catechin
- aldehyde
- catechol
- artificial antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010093096 Immobilized Enzymes Proteins 0.000 title claims abstract description 32
- 238000010276 construction Methods 0.000 title claims abstract description 19
- 239000000427 antigen Substances 0.000 title claims abstract description 12
- 102000004190 Enzymes Human genes 0.000 claims abstract description 81
- 108090000790 Enzymes Proteins 0.000 claims abstract description 81
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims abstract description 48
- 239000000463 material Substances 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 22
- 239000002262 Schiff base Substances 0.000 claims abstract description 13
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000004753 Schiff bases Chemical class 0.000 claims abstract description 10
- 229940088598 enzyme Drugs 0.000 claims description 92
- 230000000694 effects Effects 0.000 claims description 63
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 36
- 235000005487 catechin Nutrition 0.000 claims description 36
- 229950001002 cianidanol Drugs 0.000 claims description 36
- 238000006243 chemical reaction Methods 0.000 claims description 33
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 28
- 102000004882 Lipase Human genes 0.000 claims description 26
- 239000004367 Lipase Substances 0.000 claims description 26
- 108090001060 Lipase Proteins 0.000 claims description 26
- 235000019421 lipase Nutrition 0.000 claims description 26
- 239000000243 solution Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 24
- 102000004139 alpha-Amylases Human genes 0.000 claims description 24
- 108090000637 alpha-Amylases Proteins 0.000 claims description 24
- 229940024171 alpha-amylase Drugs 0.000 claims description 24
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 19
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- -1 catechin aldehyde Chemical class 0.000 claims description 18
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 16
- 239000012046 mixed solvent Substances 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 10
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 9
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 9
- WMGVPDQNPUQRND-UHFFFAOYSA-N (2-methylphenyl)acetonitrile Chemical compound CC1=CC=CC=C1CC#N WMGVPDQNPUQRND-UHFFFAOYSA-N 0.000 claims description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 8
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 8
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- CDXSJGDDABYYJV-UHFFFAOYSA-N acetic acid;ethanol Chemical group CCO.CC(O)=O CDXSJGDDABYYJV-UHFFFAOYSA-N 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000008055 phosphate buffer solution Substances 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 4
- QLNOVKKVHFRGMA-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical group [CH2]CC[Si](OC)(OC)OC QLNOVKKVHFRGMA-UHFFFAOYSA-N 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 238000011084 recovery Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 229940007550 benzyl acetate Drugs 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- ZMXYNJXDULEQCK-UHFFFAOYSA-N 2-amino-p-cresol Chemical compound CC1=CC=C(O)C(N)=C1 ZMXYNJXDULEQCK-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229920000344 molecularly imprinted polymer Polymers 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- SYDNSSSQVSOXTN-UHFFFAOYSA-N 2-nitro-p-cresol Chemical compound CC1=CC=C(O)C([N+]([O-])=O)=C1 SYDNSSSQVSOXTN-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241001417524 Pomacanthidae Species 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/087—Acrylic polymers
Landscapes
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
技术领域technical field
本发明属于固定化酶技术领域,具体涉及一种基于人工抗体-抗原的固定化酶体系的构建方法与应用。The invention belongs to the technical field of immobilized enzymes, in particular to a construction method and application of an artificial antibody-antigen-based immobilized enzyme system.
背景技术Background technique
酶作为一种催化剂具有反应温和,无污染,催化效率高的特点。但是游离酶存在对外界环境敏感、稳定性差、易失活的缺点。将酶固定在基质材料上可弥补这一缺点(CesarMateo,Jose Palomo,Gloria Fernandez-Lorente,et al.Improvement of enzymeactivity,stability and selectivity via immobilization techniques[J].Enzyme and Microbial Technology,2007,40:1451–1463)。常规的固定化酶方法包括物理吸附、包埋包封(María Fernández-Fernández,SanromáAngeles,Moldes Diego.Recent developments and applications of immobilized laccase[J].Biotechnology Advances,2013,31:1808–1825)和共价交联(Júlio César dos Santos,Patrícia Daniela Mijone,Gisel e Fátima Morais Nunes,et al.Covalent attachment of Candida rugosalipase on chemically modified hybrid matrix of polysiloxane–polyvinyl alcoholwith different activating compounds[J].Journal of Chromatography B,2007,61:229–236)。这些传统的固定化酶方法在提高了酶的稳定性、实现了酶的重复利用的同时,实现了酶的定量固定。但是传统固定化酶方法存在着特异性低、生物相容性不佳、重复使用效果差等弊端。为解决以上问题,受DNA双螺旋碱基互补配对、抗原-抗体间识别等的启发,天然分子被引入固定化酶系统用于解决特异性识别问题。然而,天然抗体或DNA链等生物分子材料自身存在着造价昂贵、稳定性差、不易保存的缺点(Re nberg,Kae Sato,KazumaMawatari,et al.Serial DNA immobilization in micro-an d extended nanospacechannels[J].Lab on a Chip,2009,9:1517–1523;Yun Liu,Huixiang Wang,JingyuHuang,Jie Yang,Baohong Liu,Pengyuan Yang,Microchip-based ELISA strategy forthe detection of low-level disease biomarker in serum,An alytica ChimicaActa,650(2009)77–82)。As a catalyst, enzyme has the characteristics of mild reaction, no pollution and high catalytic efficiency. However, free enzymes have the disadvantages of being sensitive to the external environment, poor in stability, and easily inactivated. Immobilizing the enzyme on the matrix material can make up for this shortcoming (CesarMateo, Jose Palomo, Gloria Fernandez-Lorente, et al.Improvement of enzymeactivity, stability and selectivity via immobilization techniques[J].Enzyme and Microbial Technology,2007,40:1451 –1463). Conventional enzyme immobilization methods include physical adsorption, entrapment and encapsulation (María Fernández-Fernández, Sanromá Angeles, Moldes Diego.Recent developments and applications of immobilized laccase[J].Biotechnology Advances,2013,31:1808–1825) and covalent Crosslinking (Júlio César dos Santos, Patrícia Daniela Mijone, Gisel e Fátima Morais Nunes, et al. Covalent attachment of Candida rugosalipase on chemically modified hybrid matrix of polysiloxane–polyvinyl alcohol with different activating compounds[ J]. Journal of Chromatography B, 2007, 61:229–236). These traditional immobilized enzyme methods have improved the stability of the enzyme and realized the reuse of the enzyme, and at the same time realized the quantitative immobilization of the enzyme. However, the traditional immobilized enzyme method has disadvantages such as low specificity, poor biocompatibility, and poor reusable effect. In order to solve the above problems, inspired by DNA double helix base pairing, antigen-antibody recognition, etc., natural molecules were introduced into immobilized enzyme systems to solve specific recognition problems. However, biomolecular materials such as natural antibodies or DNA chains have the disadvantages of high cost, poor stability, and difficult preservation ( Renberg, Kae Sato, KazumaMawatari, et al.Serial DNA immobilization in micro-and extended nanospacechannels[J].Lab on a Chip,2009,9:1517–1523; Yun Liu,Huixiang Wang,JingyuHuang,Jie Yang,Baohong Liu, Pengyuan Yang, Microchip-based ELISA strategy for the detection of low-level disease biomarker in serum, An alytica ChimicaActa, 650 (2009) 77–82).
发明内容Contents of the invention
本发明的目的在于提供一种基于人工抗体-抗原的固定化酶体系的构建方法与应用,通过对酶进行共价修饰作为抗原,与人工抗体材料间通过特异性识别,在实现酶的特异性定向固定的同时,降低成本、提高酶的稳定性,并且载酶量很高。The purpose of the present invention is to provide a construction method and application of an immobilized enzyme system based on an artificial antibody-antigen, by covalently modifying the enzyme as an antigen, and through specific recognition with the artificial antibody material, the specificity of the enzyme can be achieved At the same time of directional immobilization, the cost is reduced, the stability of the enzyme is improved, and the enzyme loading capacity is high.
为了实现上述目的,本发明采用以下技术方案:In order to achieve the above object, the present invention adopts the following technical solutions:
本发明一方面提供一种基于人工抗体-抗原的固定化酶体系的构建方法,所述方法包括如下步骤:One aspect of the present invention provides a method for constructing an immobilized enzyme system based on an artificial antibody-antigen, the method comprising the following steps:
(1)将Fe3O4纳米粒子分散于乙醇-水混合溶剂体系中,碱性环境下与正硅酸乙酯混匀,得到Fe3O4@SiO2;(1) Disperse Fe 3 O 4 nanoparticles in an ethanol-water mixed solvent system, and mix them with tetraethyl orthosilicate in an alkaline environment to obtain Fe 3 O 4 @SiO 2 ;
(2)将步骤(1)制得的Fe3O4@SiO2分散于甲苯中,加入三乙胺、α-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS),在氮气保护下回流混匀,得到Fe3O4@SiO2@MPS;(2) Disperse the Fe 3 O 4 @SiO 2 prepared in step (1) in toluene, add triethylamine, α-3-(trimethoxysilyl)propyl methacrylate (MPS), and Reflux and mix under protection to obtain Fe 3 O 4 @SiO 2 @MPS;
(3)以儿茶酚为模板分子,将步骤(2)制得的Fe3O4@SiO2@MPS与儿茶酚、α-甲基丙烯酸、二甲基丙烯酸乙二醇酯、偶氮二异丁腈在甲苯-乙腈混合溶液进行聚合反应,随后用洗脱液将儿茶酚洗脱掉,制得人工抗体材料;(3) Using catechol as a template molecule, combine the Fe 3 O 4 @SiO 2 @MPS prepared in step (2) with catechol, α-methacrylic acid, ethylene glycol dimethacrylate, azo Diisobutyronitrile is polymerized in a toluene-acetonitrile mixed solution, and then the catechol is eluted with an eluent to prepare an artificial antibody material;
(4)将酶分子与儿茶醛在缓冲溶液中进行席夫碱反应,得到儿茶醛-酶复合物溶液;(4) performing a Schiff base reaction on the enzyme molecule and catechin aldehyde in a buffer solution to obtain a catechin aldehyde-enzyme complex solution;
(5)将步骤(4)得到的儿茶醛-酶复合物溶液加入到步骤(3)制得的人工抗体材料中,混匀,进行酶的固定化。(5) Add the catechin aldehyde-enzyme complex solution obtained in step (4) to the artificial antibody material prepared in step (3), mix well, and immobilize the enzyme.
本发明的原理为:以Fe3O4为磁芯,用正硅酸乙酯对其进行改性,在其表面包裹上一层SiO2后,利用硅烷偶联剂MPS在其表面接枝双键,以儿茶酚为“抗原”模板分子,构建儿茶酚分子印迹聚合物,即人工抗体材料;随后选择与“抗原”模板分子结构相仿的儿茶醛,利用酚羟基对位的醛基与酶分子上的胺基通过席夫碱反应结合形成儿茶醛-酶复合物;然后利用酚羟基端与儿茶酚分子印迹聚合物间的特异性识别将复合物连接到人工抗体材料上,实现酶的固定。The principle of the present invention is: take Fe 3 O 4 as the magnetic core, modify it with tetraethyl orthosilicate, wrap a layer of SiO 2 on its surface, use silane coupling agent MPS to graft bis bond, using catechol as the "antigen" template molecule to construct the catechol molecularly imprinted polymer, that is, the artificial antibody material; then select the catechin aldehyde similar to the "antigen" template molecular structure, and use the aldehyde group at the para-position of the phenolic hydroxyl group Combine with the amine group on the enzyme molecule through Schiff base reaction to form a catechin-enzyme complex; then use the specific recognition between the phenolic hydroxyl end and the catechol molecularly imprinted polymer to link the complex to the artificial antibody material, Enzyme immobilization is achieved.
上述技术方案中,进一步地,步骤(1)中,步骤(1)中,所述Fe3O4纳米粒子的粒径为100-400nm;In the above technical solution, further, in step (1), in step (1), the particle diameter of the Fe3O4 nanoparticles is 100-400nm ;
所述乙醇-水混合溶剂体系中,乙醇与水的体积比为4:1;In the ethanol-water mixed solvent system, the volume ratio of ethanol to water is 4:1;
所述碱性环境由氨水提供,所述氨水与正硅酸乙酯的体积比为2:1;The alkaline environment is provided by ammonia water, and the volume ratio of the ammonia water to tetraethyl orthosilicate is 2:1;
所述Fe3O4与正硅酸乙酯的摩尔比为1:5-1:10。The molar ratio of Fe 3 O 4 to ethyl orthosilicate is 1:5-1:10.
上述技术方案中,进一步地,步骤(2)中,所述三乙胺与α-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS)的体积比为1:1-1:3,所述Fe3O4@SiO2的质量与α-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS)的体积之比为0.1-0.5g:1mL。In the above technical solution, further, in step (2), the volume ratio of the triethylamine to 3-(trimethoxysilyl)propyl α-methacrylate (MPS) is 1:1-1:3 , the ratio of the mass of Fe 3 O 4 @SiO 2 to the volume of 3-(trimethoxysilyl)propyl α-methacrylate (MPS) is 0.1-0.5g:1mL.
上述技术方案中,进一步地,所述甲苯-乙腈混合溶液中甲苯与乙腈的体积比为1:1-1:5。In the above technical solution, further, the volume ratio of toluene to acetonitrile in the toluene-acetonitrile mixed solution is 1:1-1:5.
上述技术方案中,进一步地,步骤(3)中,所述儿茶酚摩尔质量与Fe3O4@Si O2@MPS质量之比为1-3mmol:1g,所述儿茶酚与α-甲基丙烯酸(MAA)的摩尔比为1:2-1:6,所述儿茶酚与乙二醇二甲基丙烯酸酯(EGDMA)的摩尔比为1:5-1:20;In the above technical scheme, further, in step (3), the ratio of the molar mass of catechol to the mass of Fe 3 O 4 @Si O 2 @MPS is 1-3mmol:1g, and the ratio of catechol to α- The molar ratio of methacrylic acid (MAA) is 1:2-1:6, and the molar ratio of catechol to ethylene glycol dimethacrylate (EGDMA) is 1:5-1:20;
所述聚合反应温度为60-80℃,时间为12-24h;The polymerization reaction temperature is 60-80°C, and the time is 12-24h;
所述洗脱液为乙酸、乙醇体积比为9:1的乙酸-乙醇混合溶液。The eluent is an acetic acid-ethanol mixed solution with a volume ratio of acetic acid and ethanol of 9:1.
上述技术方案中,进一步地,步骤(4)中,所述缓冲溶液为0.01M的磷酸盐缓冲溶液;所述酶分子为脂肪酶、α-淀粉酶、α-葡萄糖苷酶中的任意一种;In the above-mentioned technical scheme, further, in step (4), the buffer solution is a 0.01M phosphate buffer solution; the enzyme molecule is any one of lipase, α-amylase, and α-glucosidase ;
所述儿茶醛与脂肪酶质量比为1:50-1:250,所述儿茶醛与α-淀粉酶质量比为1:10-1:40,所述α-葡萄糖苷酶的活力与儿茶醛的质量之比为200-1500U:1μg;The mass ratio of catechin to lipase is 1:50-1:250, the mass ratio of catechin to α-amylase is 1:10-1:40, and the activity of the α-glucosidase is comparable to The mass ratio of catechin aldehyde is 200-1500U: 1μg;
所述儿茶醛与酶分子席夫碱反应的反应温度为20-60℃,反应酸碱度为6-8,反应时间为1-6h。The reaction temperature of the reaction between the catechin aldehyde and the enzyme molecule Schiff base is 20-60°C, the reaction pH is 6-8, and the reaction time is 1-6h.
上述技术方案中,进一步地,步骤(4)中,所述儿茶醛与酶分子席夫碱反应参数需要根据酶的种类不同进行优化:In the above technical scheme, further, in step (4), the reaction parameters between the catechin and the enzyme molecule Schiff base need to be optimized according to the different types of enzymes:
脂肪酶与儿茶醛席夫碱反应优化条件为:反应温度优选为40-52℃,酸碱度优选为7.2-7.6;The optimal conditions for the reaction of lipase and catechin aldehyde Schiff base are as follows: the reaction temperature is preferably 40-52°C, and the pH is preferably 7.2-7.6;
α-淀粉酶与儿茶醛席夫碱反应优化条件为:反应温度优选为20-45℃,酸碱度优选为6.5-7.6。The optimal conditions for the reaction between α-amylase and catechin aldehyde Schiff base are as follows: the reaction temperature is preferably 20-45° C., and the pH is preferably 6.5-7.6.
α-葡萄糖苷酶与儿茶醛席夫碱反应优化条件为:反应温度优选为35-55℃,酸碱度优选为6.5-7.6。The optimal conditions for the reaction between α-glucosidase and catechin aldehyde Schiff base are as follows: the reaction temperature is preferably 35-55° C., and the pH is preferably 6.5-7.6.
上述技术方案中,进一步地,步骤(5)中,所述人工抗体聚合物与儿茶醛-酶复合物的用量关系为:每1mL儿茶醛-酶复合物中加入5-20mg人工抗体材料;In the above technical solution, further, in step (5), the dosage relationship between the artificial antibody polymer and the catechin aldehyde-enzyme complex is as follows: 5-20 mg of artificial antibody material is added to every 1 mL of the catechin aldehyde-enzyme complex ;
所述混匀速度为100-300rpm;The mixing speed is 100-300rpm;
所述酶的固定化时间为1-24h,固载温度为10-60℃。The immobilization time of the enzyme is 1-24h, and the immobilization temperature is 10-60°C.
本发明另一方面提供一种上述的构建方法在生物催化领域中的应用。Another aspect of the present invention provides an application of the above construction method in the field of biocatalysis.
本发明具有以下有益效果:The present invention has the following beneficial effects:
1、本发明方法简单便捷,在实现酶的特异性定向固定的同时,能够降低成本,提高酶的稳定性,并且具有较高的固载率,固载率达到60%以上,突破了传统的固定化酶材料仅能实现定量固定、利用生物分子材料进行定向固定化酶又价格昂贵的缺点,为简单便捷实惠的特异性定向固定化创造了条件。1. The method of the present invention is simple and convenient. While realizing the specific and directional immobilization of the enzyme, it can reduce the cost, improve the stability of the enzyme, and has a high immobilization rate, which can reach more than 60%, breaking through the traditional method. Immobilized enzyme materials can only achieve quantitative immobilization, and the disadvantages of using biomolecular materials for directional immobilization of enzymes are expensive, creating conditions for simple, convenient and affordable specific directional immobilization.
2、本发明利用人工抗体材料固定酶不仅具有良好的固载效果,同时具有较高的酶活;2. The invention uses artificial antibody materials to immobilize enzymes, which not only has a good immobilization effect, but also has high enzyme activity;
3、本发明以Fe3O4为磁芯,使固定化酶易于与溶液体系分离,可实现重复使用。3. The present invention uses Fe 3 O 4 as the magnetic core, so that the immobilized enzyme can be easily separated from the solution system and can be reused.
附图说明Description of drawings
图1为本发明人工抗体-抗原固定化酶体系构建过程示意图。Fig. 1 is a schematic diagram of the construction process of the artificial antibody-antigen immobilized enzyme system of the present invention.
具体实施方式Detailed ways
下面通过具体实施方式来进一步说明本发明的技术方案,本领域人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。The technical solutions of the present invention will be further described below through specific embodiments. Those skilled in the art should understand that the embodiments are only for helping to understand the present invention, and should not be regarded as specific limitations to the present invention.
实施例1Example 1
本实施例对脂肪酶进行固定化酶体系的构建,构建方法包括如下步骤:This embodiment carries out the construction of immobilized enzyme system to lipase, and construction method comprises the following steps:
(1)将0.6g Fe3O4纳米粒子分散于200mL乙醇与水的体积比为4:1的乙醇-水混合溶剂体系中,加入8mL氨水、4mL正硅酸乙酯,35℃混匀6h,得到Fe3O4@SiO2;(1) Disperse 0.6g of Fe 3 O 4 nanoparticles in 200mL of ethanol-water mixed solvent system with a volume ratio of ethanol and water of 4:1, add 8mL of ammonia water and 4mL of ethyl orthosilicate, and mix at 35°C for 6h , to get Fe 3 O 4 @SiO 2 ;
(2)取0.5g步骤(1)制得的Fe3O4@SiO2分散于50mL甲苯中,加入1mL三乙胺、2mLα-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS),在氮气保护下回流混匀,得到Fe3O4@SiO2@MPS;(2) Disperse 0.5 g of Fe 3 O 4 @SiO 2 prepared in step (1) in 50 mL of toluene, add 1 mL of triethylamine, 2 mL of α-3-(trimethoxysilyl)propyl methacrylate (MPS ), reflux and mix under the protection of nitrogen to obtain Fe 3 O 4 @SiO 2 @MPS;
(3)取0.2g步骤(2)制得的Fe3O4@SiO2@MPS与0.25mmol儿茶酚、0.5mmolα-甲基丙烯酸、2.5mmol二甲基丙烯酸乙二醇酯、20mg偶氮二异丁腈在60℃下在体积比为4:1的甲苯-乙腈混合溶剂体系中聚合反应24h,随后用乙酸与乙醇体积比为9:1的乙酸-乙醇混合溶液将儿茶酚洗脱掉,制得人工抗体材料;(3) Take 0.2g of Fe 3 O 4 @SiO 2 @MPS prepared in step (2) and 0.25mmol catechol, 0.5mmol α-methacrylic acid, 2.5mmol ethylene glycol dimethacrylate, 20mg azo Diisobutyronitrile was polymerized at 60°C in a toluene-acetonitrile mixed solvent system with a volume ratio of 4:1 for 24 hours, and then the catechol was eluted with an acetic acid-ethanol mixed solution with a volume ratio of acetic acid and ethanol of 9:1 drop, to produce artificial antibody materials;
(4)将脂肪酶与儿茶醛在浓度为0.01M的磷酸盐缓冲溶液中进行席夫碱反应,得到儿茶醛-酶复合物溶液;反应条件为:儿茶醛溶液浓度为25μg/mL、α-淀粉酶浓度为4mg/mL,反应温度为50℃,酸碱度为7.5,反应时间为4h;(4) Perform Schiff base reaction of lipase and catechin aldehyde in a phosphate buffer solution with a concentration of 0.01M to obtain a catechin aldehyde-enzyme complex solution; the reaction conditions are: the concentration of catechin aldehyde solution is 25 μg/mL , The concentration of α-amylase is 4mg/mL, the reaction temperature is 50°C, the pH is 7.5, and the reaction time is 4h;
(5)将1mL步骤(4)得到的儿茶醛-酶复合物溶液加入到5mg的步骤(3)制得的人工抗体材料中,使用转速为300rpm的混匀仪混匀,进行酶的固定化,固定化时间为11小时,固定化温度为20℃,得到固定化脂肪酶。(5) Add 1 mL of the catechin aldehyde-enzyme complex solution obtained in step (4) to 5 mg of the artificial antibody material prepared in step (3), and mix with a mixer with a rotation speed of 300 rpm to immobilize the enzyme The immobilization time was 11 hours, and the immobilization temperature was 20° C. to obtain immobilized lipase.
实施例2Example 2
本实施例对α-淀粉酶进行固定化酶体系的构建,构建方法包括如下步骤:In this embodiment, the construction of an immobilized enzyme system for α-amylase is carried out. The construction method includes the following steps:
(1)将0.6g Fe3O4纳米粒子分散于200mL乙醇与水的体积比为4:1的乙醇-水混合溶剂体系中,加入8mL氨水、4mL正硅酸乙酯,35℃混匀6h,得到Fe3O4@SiO2;(1) Disperse 0.6g of Fe 3 O 4 nanoparticles in 200mL of ethanol-water mixed solvent system with a volume ratio of ethanol and water of 4:1, add 8mL of ammonia water and 4mL of ethyl orthosilicate, and mix at 35°C for 6h , to get Fe 3 O 4 @SiO 2 ;
(2)取0.5g步骤(1)制得的Fe3O4@SiO2分散于50mL甲苯中,加入1mL三乙胺、2mLα-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS),在氮气保护下回流混匀,得到Fe3O4@SiO2@MPS;(2) Disperse 0.5 g of Fe 3 O 4 @SiO 2 prepared in step (1) in 50 mL of toluene, add 1 mL of triethylamine, 2 mL of α-3-(trimethoxysilyl)propyl methacrylate (MPS ), reflux and mix under the protection of nitrogen to obtain Fe 3 O 4 @SiO 2 @MPS;
(3)取0.2g步骤(2)制得的Fe3O4@SiO2@MPS与0.25mmol儿茶酚、0.5mmolα-甲基丙烯酸、2.5mmol二甲基丙烯酸乙二醇酯、20mg偶氮二异丁腈在60℃下在体积比为4:1的甲苯-乙腈混合溶剂体系中聚合反应24h,随后用乙酸与乙醇体积比为9:1的乙酸-乙醇混合溶液将儿茶酚洗脱掉,制得人工抗体材料;(3) Take 0.2g of Fe 3 O 4 @SiO 2 @MPS prepared in step (2) and 0.25mmol catechol, 0.5mmol α-methacrylic acid, 2.5mmol ethylene glycol dimethacrylate, 20mg azo Diisobutyronitrile was polymerized at 60°C in a toluene-acetonitrile mixed solvent system with a volume ratio of 4:1 for 24 hours, and then the catechol was eluted with an acetic acid-ethanol mixed solution with a volume ratio of acetic acid and ethanol of 9:1 drop, to produce artificial antibody materials;
(4)将α-淀粉酶与的儿茶醛在浓度为0.01M的磷酸盐缓冲溶液中进行席夫碱反应,得到儿茶醛-酶复合物溶液;反应条件为:儿茶醛溶液浓度为30μg/mL、α-淀粉酶浓度为1mg/mL,反应温度为36℃,酸碱度为6.8,反应时间为5h;(4) Carry out Schiff base reaction with the catechin aldehyde of α-amylase and the phosphate buffer solution that concentration is 0.01M, obtain catechin aldehyde-enzyme complex solution; Reaction condition is: the concentration of catechin aldehyde solution is 30μg/mL, the concentration of α-amylase is 1mg/mL, the reaction temperature is 36°C, the pH is 6.8, and the reaction time is 5h;
(5)将1mL步骤(4)得到的儿茶醛-酶复合物溶液加入到5mg的步骤(3)制得的人工抗体材料中,使用转速为300rpm的混匀仪混匀,进行酶的固定化,固定化时间为11h,固定化温度为20℃,得到固定化脂肪酶。(5) Add 1 mL of the catechin aldehyde-enzyme complex solution obtained in step (4) to 5 mg of the artificial antibody material prepared in step (3), and mix with a mixer with a rotation speed of 300 rpm to immobilize the enzyme The immobilization time was 11 h, and the immobilization temperature was 20° C. to obtain immobilized lipase.
实施例3Example 3
本实施例对α-葡萄糖苷酶进行固定化酶体系的构建,构建方法包括如下步骤:This embodiment carries out the construction of immobilized enzyme system to α-glucosidase, and construction method comprises the following steps:
(1)将0.6gFe3O4纳米粒子分散于200mL乙醇与水的体积比为4:1的乙醇-水混合溶剂体系中,加入8mL氨水、4mL正硅酸乙酯,35℃混匀6h,得到Fe3O4@SiO2;(1) Disperse 0.6g of Fe 3 O 4 nanoparticles in 200 mL of ethanol-water mixed solvent system with a volume ratio of ethanol and water of 4:1, add 8 mL of ammonia water, 4 mL of tetraethyl orthosilicate, and mix at 35°C for 6 hours. Get Fe 3 O 4 @SiO 2 ;
(2)取0.5g步骤(1)制得的Fe3O4@SiO2分散于50mL甲苯中,加入1mL三乙胺、2mLα-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS),在氮气保护下回流混匀,得到Fe3O4@SiO2@MPS;(2) Disperse 0.5 g of Fe 3 O 4 @SiO 2 prepared in step (1) in 50 mL of toluene, add 1 mL of triethylamine, 2 mL of α-3-(trimethoxysilyl)propyl methacrylate (MPS ), reflux and mix under the protection of nitrogen to obtain Fe 3 O 4 @SiO 2 @MPS;
(3)取0.2g步骤(2)制得的Fe3O4@SiO2@MPS与0.25mmol儿茶酚、0.5mmolα-甲基丙烯酸、2.5mmol二甲基丙烯酸乙二醇酯、20mg偶氮二异丁腈在60℃下在体积比为4:1的甲苯-乙腈混合溶剂体系中聚合反应24h,随后用乙酸与乙醇体积比为9:1的乙酸-乙醇混合溶液将儿茶酚洗脱掉,制得人工抗体材料;(3) Take 0.2g of Fe 3 O 4 @SiO 2 @MPS prepared in step (2) and 0.25mmol catechol, 0.5mmol α-methacrylic acid, 2.5mmol ethylene glycol dimethacrylate, 20mg azo Diisobutyronitrile was polymerized at 60°C in a toluene-acetonitrile mixed solvent system with a volume ratio of 4:1 for 24 hours, and then the catechol was eluted with an acetic acid-ethanol mixed solution with a volume ratio of acetic acid and ethanol of 9:1 drop, to produce artificial antibody materials;
(4)将α-葡萄糖苷酶与的儿茶醛在浓度为0.01M的磷酸盐缓冲溶液中进行席夫碱反应,得到儿茶醛-酶复合物溶液;反应条件为:儿茶醛溶液浓度为28μg/mL、α-葡萄糖苷酶与儿茶醛溶液的体积比为2.5%,反应温度为45℃,酸碱度为7.3,反应时间为5h;(4) Carry out Schiff base reaction with α-glucosidase and catechin aldehyde in the phosphate buffer solution of 0.01M, obtain catechin aldehyde-enzyme complex solution; Reaction condition is: catechin aldehyde solution concentration 28 μg/mL, the volume ratio of α-glucosidase to catechin aldehyde solution is 2.5%, the reaction temperature is 45°C, the pH is 7.3, and the reaction time is 5h;
(5)将1mL步骤(4)得到的儿茶醛-酶复合物溶液加入到5mg的步骤(3)制得的人工抗体材料中,使用转速为300rpm的混匀仪混匀,进行酶的固定化,固定化时间为11h,固定化温度为20℃,得到固定化脂肪酶。(5) Add 1 mL of the catechin aldehyde-enzyme complex solution obtained in step (4) to 5 mg of the artificial antibody material prepared in step (3), and mix with a mixer with a rotation speed of 300 rpm to immobilize the enzyme The immobilization time was 11 h, and the immobilization temperature was 20° C. to obtain immobilized lipase.
对比例1Comparative example 1
与实施例1的区别在于,基质材料的不同,为非人工抗体材料,其他过程与实施例1完全一致;The difference from Example 1 is that the matrix material is a non-artificial antibody material, and other processes are completely consistent with Example 1;
所述非人工抗体材料的制备方法为:The preparation method of the non-artificial antibody material is:
(1)将0.6g Fe3O4纳米粒子分散于200mL乙醇与水的体积比为4:1的乙醇-水混合溶剂体系中,加入8mL氨水、4mL正硅酸乙酯,35℃混匀6h,得到Fe3O4@SiO2;(1) Disperse 0.6g of Fe 3 O 4 nanoparticles in 200mL of ethanol-water mixed solvent system with a volume ratio of ethanol and water of 4:1, add 8mL of ammonia water and 4mL of ethyl orthosilicate, and mix at 35°C for 6h , to get Fe 3 O 4 @SiO 2 ;
(2)取0.5g步骤(1)制得的Fe3O4@SiO2分散于50mL甲苯中,加入1mL三乙胺、2mLα-甲基丙烯酸3-(三甲氧基硅基)丙酯(MPS),在氮气保护下回流混匀,得到Fe3O4@SiO2@MPS;(2) Disperse 0.5 g of Fe 3 O 4 @SiO 2 prepared in step (1) in 50 mL of toluene, add 1 mL of triethylamine, 2 mL of α-3-(trimethoxysilyl)propyl methacrylate (MPS ), reflux and mix under the protection of nitrogen to obtain Fe 3 O 4 @SiO 2 @MPS;
(3)取0.2g步骤(2)制得的Fe3O4@SiO2@MPS与0.5mmolα-甲基丙烯酸、2.5mmol二甲基丙烯酸乙二醇酯、20mg偶氮二异丁腈在60℃下在体积比为4:1的甲苯-乙腈混合溶剂体系中聚合反应24h,随后用乙酸与乙醇体积比为9:1的乙酸-乙醇混合溶液将儿茶酚洗脱掉,制得非人工抗体材料。(3) Take 0.2g of Fe 3 O 4 @SiO 2 @MPS prepared in step (2) and 0.5mmol α-methacrylic acid, 2.5mmol ethylene glycol dimethacrylate, 20mg azobisisobutyronitrile at 60 Polymerize in a mixed solvent system of toluene-acetonitrile with a volume ratio of 4:1 at ℃ for 24 hours, then elute catechol with a mixed solution of acetic acid-ethanol with a volume ratio of acetic acid and ethanol of 9:1 to obtain non-artificial Antibody material.
对比例2Comparative example 2
与实施例2的区别在于,基质材料的不同,采用对比例1中的非人工抗体材料,其他过程与实施例2完全一致。The difference from Example 2 is that the matrix material is different, and the non-artificial antibody material in Comparative Example 1 is used, and other processes are completely consistent with Example 2.
对比例3Comparative example 3
与实施例3的区别在于,基质材料的不同,采用对比例1中的非人工抗体材料,其他过程与实施例3完全一致。The difference from Example 3 is that the matrix material is different, and the non-artificial antibody material in Comparative Example 1 is used, and other processes are completely consistent with Example 3.
性能测试:Performance Testing:
对实施例1、实施例2、实施例3与对比例1、对比例2、对比例3制得的固定化酶材料进行性能测试,方法如下:Carry out performance test to the immobilized enzyme material that embodiment 1, embodiment 2, embodiment 3 and comparative example 1, comparative example 2, comparative example 3 make, method is as follows:
(1)载酶量:(1) Enzyme load:
通过用考马斯亮蓝法在紫外595nm下测定固载前后上清酶液吸光度,代入BS A牛血清蛋白标准曲线,确定固载前后蛋白质浓度来计算固载率、固载量。The absorbance of the supernatant enzyme solution before and after immobilization was measured by the Coomassie brilliant blue method at UV 595nm, substituted into the BSA bovine serum albumin standard curve, and the protein concentration before and after immobilization was determined to calculate the immobilization rate and immobilization amount.
固载率公式:Yield(%)=(C0-Ct)/C0×100%The formula of loading rate: Yield(%)=(C 0 -C t )/C 0 ×100%
固载量公式:固载量=(C0-Ct)×V×1000/MSolid loading formula: solid loading = (C 0 -C t )×V×1000/M
其中C0为固载前蛋白质浓度、Ct为固载后蛋白质浓度、V为固载所用的溶液体积、M为基质质量。Where C 0 is the protein concentration before immobilization, C t is the protein concentration after immobilization, V is the volume of the solution used for immobilization, and M is the mass of the matrix.
(2)酶活性定义为每分钟水解1μmol底物或产生1μmol产物所消耗的酶量定义为1U。(2) Enzyme activity is defined as the amount of enzyme consumed to hydrolyze 1 μmol of substrate or produce 1 μmol of product per minute, which is defined as 1U.
(3)酶的重复使用性(3) Reusability of enzymes
将首次测定的酶活力定义为100%、随后利用磁铁将固定化酶从溶液体系中分离出来后,重复测定活性,比较重复测定与首次测定的比例。The enzyme activity measured for the first time was defined as 100%, and after the immobilized enzyme was separated from the solution system using a magnet, the activity was repeatedly measured, and the ratio of the repeated measurement and the first measurement was compared.
(4)固定化酶与游离酶温度适应性比较(4) Comparison of temperature adaptability between immobilized enzyme and free enzyme
测定不同温度条件下固定化酶与游离酶的活力,并分别选取最好的定义为100%,并将剩余温度活性与其进行比较。The activities of immobilized enzymes and free enzymes were measured under different temperature conditions, and the best one was selected as 100%, and the remaining temperature activity was compared with it.
(5)固定化酶与游离酶pH适应性比较(5) Comparison of pH adaptability between immobilized enzyme and free enzyme
测定不同pH条件下固定化酶与游离酶的活力,并分别选取最好的定义为100%,并将剩余pH活性与其进行比较。The activities of immobilized enzymes and free enzymes were measured under different pH conditions, and the best one was selected as 100%, and the remaining pH activity was compared with it.
性能测定结果如下:The performance measurement results are as follows:
实施例1-3与对比例1-3的固载量、酶活、重复酶活测定结果如表1所示。Table 1 shows the immobilization capacity, enzyme activity and repeated enzyme activity determination results of Examples 1-3 and Comparative Examples 1-3.
表1Table 1
实施例1的人工抗体-抗原固定化酶体系对脂肪酶的固载量为13.22mgprotein/gsupp ort、初始酶活性为104.66U/gsupport、固载率为73.58%、重复使用时酶活性为104.30U/gsupport;对比例1的非人工抗体材料对脂肪酶的固载量则为0.77mgprotein/gsupport,较人工抗体材料固定化脂肪酶效果相差很多,具有一定的初始活性,为75.87U/gsuppor t,但是重复使用时仅剩5.17U/gsupport。The artificial antibody-antigen immobilized enzyme system of Example 1 has a lipase immobilization capacity of 13.22mg protein /g support , an initial enzyme activity of 104.66U/g support , an immobilization rate of 73.58%, and an enzyme activity of It was 104.30U/g support ; the non-artificial antibody material in Comparative Example 1 had an immobilization capacity of lipase of 0.77 mg protein /g support , which was much different from the immobilized lipase effect of the artificial antibody material, and had a certain initial activity. 75.87U/g support , but only 5.17U/g support left when reused.
实施例2的α-淀粉酶的固载量为14.78mgprotein/gsupport、初始酶活性为199.33u/gsupport、固载率为68.29%、重复使用时酶活性为199.33U/gsupport;对比例2的非人工抗体材料对α-淀粉酶的固载量为0.20mgprotein/gsupport、具有114.30U/gsupport的初始酶活性、与此同时再重复使用时活性回收效果下降迅速,仅剩29.74U/gsupport。The α-amylase of Example 2 has an immobilization capacity of 14.78mg protein /g support , an initial enzyme activity of 199.33u/g support , an immobilization rate of 68.29%, and an enzyme activity of 199.33U/g support during repeated use; The non-artificial antibody material in ratio 2 has an immobilized capacity of 0.20mg protein /g support for α-amylase, and an initial enzyme activity of 114.30U/g support . At the same time, the activity recovery effect decreases rapidly when it is reused, leaving only 29.74U/g support .
实施例3的α-葡萄糖苷酶的固载量为25.09mgprotein/gsupport、初始酶活性为143.25U/gsupport、固载率为62.84%、重复使用时酶活性为137.70U/gsupport;对比例2的非人工抗体材料对α-葡萄糖苷酶的固载量为5.91mgprotein/gsupport、初始酶活为70.29U/gsupport、重复使用时酶活性仅剩29.46U/gsupport。The α-glucosidase of Example 3 has an immobilization capacity of 25.09mg protein /g support , an initial enzyme activity of 143.25U/g support , an immobilization rate of 62.84%, and an enzyme activity of 137.70U/g support during repeated use; The non-artificial antibody material in Comparative Example 2 has an immobilization capacity of α-glucosidase of 5.91mg protein /g support , an initial enzyme activity of 70.29U/g support , and only 29.46U/g support of enzyme activity after repeated use.
与此同时,本发明实施例1-3所制备的人工抗体固定化脂肪酶、α-淀粉酶、α-葡萄糖苷酶材料在重复使用第15次时相对于初始酶活分别为62.79%、47.48%、39.85%,事实证明利用人工抗体材料固定酶不仅具有良好的固载效果,具有较高的酶活性,在重复使用时相较于非人工抗体具有较高的稳定性。At the same time, the artificial antibody-immobilized lipase, α-amylase, and α-glucosidase materials prepared in Examples 1-3 of the present invention were 62.79% and 47.48% respectively relative to the initial enzyme activity when they were reused for the 15th time. %, 39.85%. Facts have proved that using artificial antibody materials to immobilize enzymes not only has a good immobilization effect, but also has higher enzyme activity, and has higher stability than non-artificial antibodies when repeated use.
酶在被固定化后最佳酶促反应条件会有发生变化的可能,分别将游离酶与固定化酶活性的初始活性定义为100%,由实验结果可知,三种固定化酶的最佳酶促反应温度相较于游离酶都发生了变化。实施例2中α-淀粉酶在被固定化后,无论是在高温还是低温条件下活性回收效果均高于游离酶,在25℃时固定化α-淀粉酶的相对活性为77.21%,游离淀粉酶为67.68%;50℃时固定化α-淀粉酶的相对活性为95.31%,游离淀粉酶的活性则为79.76%。实施例3中α-葡萄糖苷酶被固定化后,低温条件下活性回收效果与游离酶接近,但是在高温条件下要优越于游离酶,80℃时固定化α-葡萄糖苷酶的剩余活性为47.82%,游离糖苷酶的剩余活性为38.51%。而实施例1中固定化脂肪酶在低温状态下活性回收效果则不如游离酶,但是高温状态下要比游离酶高,在50℃时,固定化脂肪酶回收活性为93.72%,而游离脂肪酶仅剩87.35%。综合来讲,用人工抗体材料对酶进行固定时,酶对较高的极端温度的适应性均有提升。After the enzyme is immobilized, the optimal enzymatic reaction conditions may change. The initial activity of the free enzyme and the immobilized enzyme activity are respectively defined as 100%. It can be seen from the experimental results that the best enzyme activity of the three immobilized enzymes The reaction temperature was changed compared with the free enzyme. In Example 2, after the α-amylase was immobilized, the activity recovery effect was higher than that of the free enzyme no matter at high temperature or low temperature. The relative activity of the immobilized α-amylase was 77.21% at 25°C, and the free starch The enzyme content is 67.68%. The relative activity of immobilized α-amylase at 50°C is 95.31%, while the activity of free amylase is 79.76%. After the α-glucosidase is immobilized in Example 3, the activity recovery effect under low temperature conditions is close to that of the free enzyme, but it is superior to the free enzyme under high temperature conditions. The residual activity of the immobilized α-glucosidase at 80°C is 47.82%, the remaining activity of free glycosidase is 38.51%. In Example 1, the activity recovery effect of immobilized lipase is not as good as that of free enzyme at low temperature, but higher than that of free enzyme at high temperature. At 50°C, the recovery activity of immobilized lipase is 93.72%, while that of free lipase Only 87.35% left. In general, when using artificial antibody materials to immobilize enzymes, the adaptability of enzymes to higher extreme temperatures is improved.
固定化脂肪酶、固定化α-淀粉酶、固定化α-葡萄糖苷酶与相应的游离酶在不同酸碱度下的活性回收效果的比较,α-葡萄糖苷酶,脂肪酶与α-淀粉酶在被固定在人工抗体材料上后酶促反应最佳pH均有变化。固定化脂肪酶在碱性条件下活性回收效果更加优异,当pH=10.5时,固定化脂肪酶活性回收率为77.27±0.25%,而游离脂肪酶活性则仅剩39.65±0.33%。尽管α-葡萄糖苷酶被固定化后在酸性条件下活性回收效果不如游离酶,但是其在碱性条件下的活性回收率要高于游离酶,当pH=9时,游离酶的活性回收效率为64.35%,而固定化酶的活性回收效果为72.72%。α-淀粉酶在被固定后无论在过酸还是过碱条件下均优越于游离酶,当pH=10.5时固定化α-淀粉酶的相对活性为82.37%,游离状态的α-淀粉酶相对活性则是69.46%。当pH=5.5时,固定化α-淀粉酶的活性回收率为89.55%,而游离状态的酶活性回收率则是81.04%整体上来说,用人工抗体材料固定化酶可以提高酶在面对过酸、过碱环境下的活性保持效果。Comparison of activity recovery effects of immobilized lipase, immobilized α-amylase, immobilized α-glucosidase and corresponding free enzymes at different pH values, α-glucosidase, lipase and α-amylase were The optimal pH of the enzymatic reaction varies after immobilized on the artificial antibody material. The activity recovery effect of the immobilized lipase is more excellent under alkaline conditions. When the pH=10.5, the recovery rate of the activity of the immobilized lipase is 77.27±0.25%, while the activity of the free lipase is only 39.65±0.33%. Although the activity recovery effect of α-glucosidase is not as good as that of free enzyme under acidic conditions after being immobilized, its activity recovery rate under alkaline conditions is higher than that of free enzyme. When pH=9, the activity recovery efficiency of free enzyme was 64.35%, while the activity recovery effect of the immobilized enzyme was 72.72%. After the α-amylase is immobilized, it is superior to the free enzyme no matter under the condition of peracid or overalkali. When the pH=10.5, the relative activity of the immobilized α-amylase is 82.37%, and the relative activity of the α-amylase in the free state It is 69.46%. When pH=5.5, the activity recovery rate of immobilized α-amylase is 89.55%, and the enzyme activity recovery rate of free state is then 81.04%. Activity retention effect in acid and over-alkali environment.
应用例1Application example 1
使用固定化脂肪酶催化合成乙酸苄酯,合成条件为:将500μL的乙酸乙烯酯与5μL的苯甲醇加入到50mg的固定化脂肪酶材料中,70℃下反应,反应6h时反应达到平衡状态;将反应6h后的混合物在70℃下将未反应的反应物蒸干后,利用液相测定反应产物乙酸苄酯产率,产率为88.72%。用磁铁将上清液与固定化脂肪酶材料分离开来后,继续加入乙酸乙烯酯与苯甲醇,连续进样5次后,所得到的乙酸苄酯产率为初次催化所得产物的74.13%。这证明了用该方法固定的脂肪酶不仅在水溶液中稳定性及重复使用性能良好,在有机溶剂中同样能保持良好的稳定性和重复使用性。Use immobilized lipase to catalyze the synthesis of benzyl acetate. The synthesis conditions are: add 500 μL of vinyl acetate and 5 μL of benzyl alcohol to 50 mg of immobilized lipase material, react at 70 ° C, and the reaction reaches an equilibrium state after 6 hours of reaction; After reacting the mixture for 6 hours, the unreacted reactants were evaporated to dryness at 70° C., and the yield of the reaction product benzyl acetate was measured by liquid phase, and the yield was 88.72%. After the supernatant was separated from the immobilized lipase material with a magnet, vinyl acetate and benzyl alcohol were added continuously. After five consecutive injections, the yield of benzyl acetate obtained was 74.13% of the product obtained by the initial catalysis. This proves that the lipase immobilized by the method not only has good stability and reusability in aqueous solution, but also maintains good stability and reusability in organic solvents.
应用例2Application example 2
使用固定化α-淀粉酶催化合成邻氨基对甲基苯酚,合成条件为:将淀粉溶液加入到固定化α-淀粉酶材料中37℃下活化10min后,将上清液吸出与2-硝基-4-甲基苯酚进行反应,在100℃反应9分钟时,产物量基本达到稳定,在275nm下利用液相进行检测,此时产率为58.88%。接下来对固定化α-淀粉酶材料催化2-氨基对甲基苯酚反应连续进样效率进行测定,5次重复使用后,催化效率为初次使用的80.86%。Use immobilized α-amylase to catalyze the synthesis of o-amino-p-cresol. The synthesis conditions are: add the starch solution to the immobilized α-amylase material and activate it at 37°C for 10 minutes, then suck out the supernatant and mix with 2-nitro -4-Methylphenol was reacted, and the product amount was basically stable when the reaction was carried out at 100° C. for 9 minutes, and the yield was 58.88% when detected by liquid phase at 275 nm. Next, the continuous sampling efficiency of the immobilized α-amylase material catalyzing the reaction of 2-amino-p-cresol was measured. After 5 times of repeated use, the catalytic efficiency was 80.86% of the initial use.
应用例3Application example 3
使用固定化α-葡萄糖苷酶催化合成4-甲基伞形酮,合成条件为:将4-甲基伞形酮-α-D-吡喃-葡萄糖苷溶液加入到固定化α-葡萄糖苷酶材料中37℃下反应,在反应30min后利用高效液相色谱在254nm下测定产率,此时反应产率为77.54%。随后对固定化α-葡萄糖苷酶催化4-甲基伞形酮-α-D-吡喃葡萄糖苷转化为4-甲基伞形酮连续进样效果进行测定。连续5次催化后,产率为初次催化的81.12%。Using immobilized α-glucosidase to catalyze the synthesis of 4-methylumbelliferone, the synthesis condition is: add 4-methylumbelliferone-α-D-glucopyranoside solution to immobilized α-glucosidase The material was reacted at 37° C., and the yield was measured by high-performance liquid chromatography at 254 nm after reacting for 30 minutes. At this time, the reaction yield was 77.54%. Then, the continuous injection effect of the immobilized α-glucosidase catalyzing the conversion of 4-methylumbelliferone-α-D-glucopyranoside into 4-methylumbelliferone was determined. After 5 consecutive catalysis, the yield was 81.12% of the initial catalysis.
应用例1-3测试结果如表2所示。The test results of application examples 1-3 are shown in Table 2.
表2Table 2
本发明主要针对人工抗体-抗原固定化酶体系的可行性进行了探究,在成功构建了单抗体固定化酶体系后,测定其性能,相较于普通固定化酶材料,人工抗体固定化酶材料的固定化效果及稳定性更加良好,最后对固定化酶材料进行了成功应用。The present invention mainly explores the feasibility of the artificial antibody-antigen immobilized enzyme system. After successfully constructing the single antibody immobilized enzyme system, its performance is measured. Compared with ordinary immobilized enzyme materials, artificial antibody immobilized enzyme materials The immobilization effect and stability are better, and finally the immobilized enzyme material has been successfully applied.
申请人声明,本发明通过上述实例来说明本发明的人工抗体-抗原固定化酶体系的制备方法和应用,但本发明并不局限于以上步骤,即不意味着必须依赖上述工艺步骤才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明所选用原料的等效替换及辅助成分的添加,具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant declares that the present invention illustrates the preparation method and application of the artificial antibody-antigen-immobilized enzyme system of the present invention through the above examples, but the present invention is not limited to the above steps, that is, it does not mean that the above process steps must be relied on for implementation. Those skilled in the art should understand that any improvement of the present invention, the equivalent replacement of selected raw materials and the addition of auxiliary components in the present invention, the selection of specific methods, etc., all fall within the scope of protection and disclosure of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310617202.XA CN116640757A (en) | 2023-05-29 | 2023-05-29 | Construction method and application of immobilized enzyme system based on artificial antibody-antigen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310617202.XA CN116640757A (en) | 2023-05-29 | 2023-05-29 | Construction method and application of immobilized enzyme system based on artificial antibody-antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116640757A true CN116640757A (en) | 2023-08-25 |
Family
ID=87624179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310617202.XA Pending CN116640757A (en) | 2023-05-29 | 2023-05-29 | Construction method and application of immobilized enzyme system based on artificial antibody-antigen |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116640757A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118146358A (en) * | 2024-05-09 | 2024-06-07 | 成都维德医疗器械有限责任公司 | Process for extracting collagen from beef tendon |
-
2023
- 2023-05-29 CN CN202310617202.XA patent/CN116640757A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118146358A (en) * | 2024-05-09 | 2024-06-07 | 成都维德医疗器械有限责任公司 | Process for extracting collagen from beef tendon |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhong et al. | Bifunctional hybrid enzyme-catalytic metal organic framework reactors for α-glucosidase inhibitor screening | |
Weetall | Preparation of immobilized proteins covalently coupled through silane coupling agents to inorganic supports | |
Mosbach | Toward the next generation of molecular imprinting with emphasis on the formation, by direct molding, of compounds with biological activity (biomimetics) | |
CN110218720A (en) | A kind of immobilised enzymes method and application improving horseradish peroxidase stability | |
CN108192007A (en) | A kind of carboxy-functionalized polyurethane coated magnetic microballoon and preparation method thereof | |
JPH03505222A (en) | Method for immobilizing proteins, peptides, coenzymes, etc. on carriers | |
Wei et al. | Surface-grafted, molecularly imprinted polymers grown from silica gel for chromatographic separations | |
CN109266639B (en) | A kind of double immobilized enzyme and its preparation method and application | |
CN116640757A (en) | Construction method and application of immobilized enzyme system based on artificial antibody-antigen | |
CN106669822A (en) | Preparation method of compound biomimetic mineralization nano biocatalyst | |
CN111471663A (en) | A method for immobilizing Pseudomonas fluorescens lipase by metal-organic framework material | |
Pidenko et al. | Proteins: templates and matrices in molecular imprinting | |
CN109749029B (en) | A kind of high molecular polymer and its preparation method and application | |
Luo et al. | Reversible two‐enzyme coimmobilization on pH‐responsive imprinted monolith for glucose detection | |
Crowther et al. | Covalent immobilisation of solvatochromic dyes | |
WO1986001902A1 (en) | Specific binding materials, their preparation and use | |
CN102154256A (en) | Carrier-free immobilized lipase and preparation method thereof | |
CN100564523C (en) | Contain epoxy group(ing) fixed enzyme vector and preparation method and purposes | |
Knežević-Jugović et al. | The immobilization of enzyme on Eupergit® supports by covalent attachment | |
CN114854730B (en) | Preparation method of in-situ encapsulation of immobilized enzyme by covalent organic network material | |
CN113398986B (en) | A kind of pH-sensitive catalyst for catalyzing asymmetric Aldol reaction and preparation method thereof | |
CN110760496B (en) | Co-crosslinking immobilization method of penicillin G acylase | |
JP4797143B2 (en) | Catalytic reaction control method | |
Arica et al. | Immobilization of glucoamylase on the plain and on the spacer arm‐attached poly (HEMA‐EGDMA) microspheres | |
Knežević-Jugović et al. | Covalent immobilization of enzymes on Eupergit® supports: effect of the immobilization protocol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |